CN100434097C - Ophidia black snake powder - Google Patents

Ophidia black snake powder Download PDF

Info

Publication number
CN100434097C
CN100434097C CNB2005100419158A CN200510041915A CN100434097C CN 100434097 C CN100434097 C CN 100434097C CN B2005100419158 A CNB2005100419158 A CN B2005100419158A CN 200510041915 A CN200510041915 A CN 200510041915A CN 100434097 C CN100434097 C CN 100434097C
Authority
CN
China
Prior art keywords
present
treatment
radix
alopecia
black snake
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005100419158A
Other languages
Chinese (zh)
Other versions
CN1843422A (en
Inventor
韩勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2005100419158A priority Critical patent/CN100434097C/en
Publication of CN1843422A publication Critical patent/CN1843422A/en
Application granted granted Critical
Publication of CN100434097C publication Critical patent/CN100434097C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to an oral health care product for treating phalacrosis in an auxiliary mode, which comprises the following components of the weight percent: 15 to 32% of black snake or pit viper, 10 to 24% of pawpaw, 16 to 23% of semen torreyae, 16 to 23% of kudzuvine root and 2 to 22% of liquorice. The present invention solves the technical problems that in the prior art, the curative effect of a product for treating phalacrosis is poor, the treatment processes are single, and adverse reactions exist.

Description

A kind of auxiliary treatment ailment said due to cold or exposure lays particular stress on the medicine of disease alopecia
One, technical field
The present invention relates to a kind of health product, especially a kind of Orally taken health article that is used for the auxiliary treatment alopecia.
Two, background technology
Since the quickening of modern life rhythm, the sharp increase of operating pressure, and various hair illness such as alopecia have brought increasing puzzlement for modern's life.The product for the treatment of alopecia in the market mostly is cosmetics, care appliance, and wherein Dai Biao product is the refreshing comb of ZHANGGUANG 101, newborn black pigment used by women in ancient times to paint their eyebrows hair growth promoting, and all there is following shortcoming in this series products:
1, therapeutic effect is poor.Because above two series products all are to be coated with by human external to touch or the mode of part massage is treated alopecia, can not enter human body, can not fundamentally improve the natural on-off cycles of hair growth environment, therefore can only cure the symptoms, not the disease, control outer do not control in, so therapeutic effect is very little.
2, no personalized treatment.More than two series products can not carry out meticulous dialectical allotment, can not accomplish to shoot the arrow at the target at dissimilar patients.
3, untoward reaction is arranged.Untoward reaction such as can occur swelling and ache when using on the hair of allergic skin body constitution.
Three, summary of the invention
The product therapeutic effect that the invention solves the treatment alopecia in the background technology is poor, do not have personalized treatment and the technical problem of untoward reaction is arranged.
Technical scheme of the present invention is: the present invention lays particular stress on the medicine of disease alopecia for a kind of auxiliary treatment ailment said due to cold or exposure, and its special character is: the percentage by weight that described auxiliary treatment ailment said due to cold or exposure lays particular stress on the medicine of disease alopecia consists of Zaocys or Agkistrodon halys 15~32%, Fructus Chaenomelis 10~24%, Semen Torreyae 16~23%, Radix Puerariae 16~23%, Radix Glycyrrhizae 2~22%.
In the said components: Zaocys or Agkistrodon halys are the best to get Zaocys, and Agkistrodon halys takes second place.
The present invention faces the card experience according to the traditional Chinese medical science several thousand, and find in the medical practice of the clinical experience of two more than ten years and treatment alopecia, the people is an integral body, hair is a part of human body, if the human physiological functions imbalance, the natural on-off cycles of hair growth environment is destroyed, and then hair comes off in a large number, hair is sparse, even bald.Therefore the present invention is according to the basic theories of the traditional Chinese medical science " organic conception ", " treatment must aim at the pathogenesis of disease ", " dialectical opinion is controlled ", simultaneously according to the function of human body of putting down in writing in Compendium of Material Medica, Shennong's Herbal, " Treatise on Dietetic Therapy " of improvement that has, the integration of edible and medicinal herbs product that can eat again, the file of the integration of edible and medicinal herbs of announcing according to health ministry, develop this health food, so the present invention has the following advantages:
1, integration of edible and medicinal herbs, therapeutic effect is good.The present invention looses in conjunction with hair growth accelerating to use together, by the oral function of human body of adjusting, improves the natural on-off cycles of hair growth environment, but treating both the principal and secondary aspects of a disease.
2, can carry out personalized treatment.The present invention can carry out meticulous dialectical allotment according to patient's different body constitution, symptom, looses in conjunction with hair growth accelerating and uses together, accomplishes personalized treatment; The present invention is mainly used in and experiences ailment said due to cold or exposure, the retardance blood vessels, and numbness of scalp pain, formicant itching, the hair fall in flakes, outbreak repeatedly, the limbs pain numbness, migratory pain, various alopecia ailment said due to cold or exposure such as white and thin fur stringy pulse lay particular stress on the auxiliary treatment of disease type.
3, had no side effect, filled up the blank of the health food of treatment alopecia.
Four, the specific embodiment
It is monarch drug that the present invention selects Zaocys or Agkistrodon halys, Fructus Chaenomelis expel wind to dredge collateral; The Semen Torreyae killing parasites for relieving itching is a ministerial drug; Radix Puerariae, Radix Glycyrrhizae priming are up, and coordinating the actions of various ingredients in a prescription makes for assistant altogether.
The consumption of component of the present invention is also groped to sum up to draw through the inventor in a large number, and each amounts of components is for all to have good efficacy in following weight percentage ranges:
Percentage by weight consumption of the present invention is: Zaocys or Agkistrodon halys 15~32%, Fructus Chaenomelis 10~24%, Semen Torreyae 16~23%, Radix Puerariae 16~23%, Radix Glycyrrhizae 2~22%.
Below be concrete proportioning example of the present invention (is unit with the percentage by weight):
Figure C20051004191500051
Production technology of the present invention following (production technology with health promoting beverage is an example):
1) each raw material is taken by weighing by proportioning;
2) raw material pulverizing that proportioning is good, sieve;
3) hybrid packed the getting final product of raw material after will sieving.
Clinical comparison experimental result of the present invention is as follows:
Lay particular stress on disease type alopecia patient at the diffusing primary symptom ailment said due to cold or exposure of hair growth accelerating, with every group 50 example, carry out 2 groups of treatments, curative effect is as follows:
Example one, matched group: the treatment of loosing of the oral hair growth accelerating of patient, every day twice, each 5 grams, with 4 weeks be a course of treatment, after 6 courses of treatment, 14 examples of fully recovering, 31 examples, invalid 5 examples take a turn for the better.
Example two, the treatment group: patient simultaneously oral hair growth accelerating looses and component is the medicine that the auxiliary treatment ailment said due to cold or exposure of Zaocys, Fructus Chaenomelis, Semen Torreyae, Radix Puerariae, Radix Glycyrrhizae lays particular stress on the disease alopecia, twice of every day, each hair growth accelerating looses and lays particular stress on each 5 gram of medicine of disease alopecia with the auxiliary treatment ailment said due to cold or exposure, with 4 weeks be a course of treatment, after 6 courses of treatment, 31 examples of fully recovering, improvement 15 examples, invalid 4 examples.
The above hair growth accelerating looses and is disclosed Chinese patent medicine preparation in the application for a patent for invention prospectus of publication number CN1504210A, and it is Rhizoma Atractylodis 1%-20% that percentage by weight is formed; Rhizoma Atractylodis Macrocephalae (parched) 1%-12%; Radix Codonopsis 3%-30%; Radix Angelicae Sinensis 2%-27%; Rhizoma Chuanxiong 1%-18%; Radix Bupleuri 3%-25%; Radix Astragali 1%-20%; Radix Polygoni Multiflori Preparata 0.5%-10%; Clear Rhizoma Pinelliae Preparata 0.5%-2%; Polyporus 1%-10%; Poria 0.5%-10%; Semen Plantaginis 0.5%-10%; Rhizoma Alismatis 0.5%-10%; Semen Coicis 3%-30%; Flos Carthami 3%-30%; Radix Saposhnikoviae 0.1%-10%; Radix Paeoniae Rubra 3%-30%; Radix Salviae Miltiorrhizae 3%-30%; Semen Persicae 3%-30%; Pericarpium Citri Reticulatae 5%-30%; Fructus Aurantii 1%-10%; Herba Pogostemonis 3%-30%; Herba Eupatorii 3%-30%; Herba Lycopi 3%-30%; Rhizoma Corydalis 3%-30%; Pericarpium Citri Reticulatae Viride 1%-30%; Cortex Magnoliae Officinalis 0.5%-20%; Radix Angelicae Dahuricae 1%-10%; Radix Platycodonis 3%-30%.

Claims (1)

1, a kind of auxiliary treatment ailment said due to cold or exposure lays particular stress on the medicine of disease alopecia, it is characterized in that: the percentage by weight of described drug component consists of Zaocys or Agkistrodon halys 15~32%, Fructus Chaenomelis 10~24%, Semen Torreyae 16~23%, Radix Puerariae 16~23%, Radix Glycyrrhizae 2~22%.
CNB2005100419158A 2005-04-07 2005-04-07 Ophidia black snake powder Expired - Fee Related CN100434097C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100419158A CN100434097C (en) 2005-04-07 2005-04-07 Ophidia black snake powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100419158A CN100434097C (en) 2005-04-07 2005-04-07 Ophidia black snake powder

Publications (2)

Publication Number Publication Date
CN1843422A CN1843422A (en) 2006-10-11
CN100434097C true CN100434097C (en) 2008-11-19

Family

ID=37062408

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100419158A Expired - Fee Related CN100434097C (en) 2005-04-07 2005-04-07 Ophidia black snake powder

Country Status (1)

Country Link
CN (1) CN100434097C (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1504210A (en) * 2002-11-28 2004-06-16 勇 韩 Prepared Chinese traditional medicine for alopecia
CN1504226A (en) * 2002-12-03 2004-06-16 涛 房 Traditional Chinese herbal medicine pilatory

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1504210A (en) * 2002-11-28 2004-06-16 勇 韩 Prepared Chinese traditional medicine for alopecia
CN1504226A (en) * 2002-12-03 2004-06-16 涛 房 Traditional Chinese herbal medicine pilatory

Also Published As

Publication number Publication date
CN1843422A (en) 2006-10-11

Similar Documents

Publication Publication Date Title
CN101961464B (en) Chinese medicinal composition for treating jaundice and preparation method thereof
CN101711850B (en) Traditional Chinese medicine composition for treating symptoms of myocardial ischemia, palpitation and severe palpitation and preparation method
CN101773650A (en) Chinese medicinal composition for treating clonic convulsion and preparation method thereof
CN102526663A (en) Medicine for treating leukotrichia
CN101284073A (en) Combination medicine for curing the hoary hair
CN100391526C (en) Powder comprising oyster and king solomonseal root
CN102068661A (en) Chinese medical formula for treating female blood stasis, blood deficiency and deep thready pulse dysmenorrhea
CN101862411B (en) Chinese medicinal composition for treating acne
CN100391518C (en) Powder containing honeysuckle flower
CN103028090A (en) Traditional Chinese medicine composition for treating Qi deficiency
CN100391511C (en) Peach kernel macrostem onion powder
CN101590104A (en) A kind of Chinese medicine for the treatment of obstructive angiitis
CN1153655A (en) Chinese medicine prepn for balancing internal secretion
CN102335336A (en) Traditional Chinese medicine for treating lupus sebaceus
CN100434111C (en) Powder containing seed of spine date, licorice and wheat
CN102416146B (en) Chinese medicinal composition for treating amenorrhea
CN101554470A (en) Traditional Chinese medicine for treating tachycardia
CN100444885C (en) Powder containing fingered citron and citron
CN104524479B (en) A kind of Chinese medicine composition for treating premenstrual syndrome and preparation method thereof
CN1238020C (en) Medicine for treating waist and lower extremities pain
CN100434110C (en) Powder comprising mint and chrysanthemum
CN100434097C (en) Ophidia black snake powder
CN103212044B (en) Traditional Chinese medicine composition for treating cardiovascular diseases
CN100434115C (en) Powder containing tuckahoe, seed of gordon euryale, coix seed and lotus seed
CN106177807A (en) A kind of Chinese medicine formula treating breast carcinoma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20081119

Termination date: 20110407